To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CEP350TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
413 supporting clones for gene CEP350 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_014810.4   .a 1 to 13454 2 to 13455 exact RefSeq, AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 13455/13455
(100 %)
0 diff
(100 %id)
AW504850 lymph .a 48 to 395 1 to 348   tiling clone,   348/348
(100 %)
5 diff
(98.6 %id)
AF287356   .a 216 to 11955 1 to 11740 S114G E459R E945Q S2164P tiling clone,   11740/11740
(100 %)
8 diff
(100.0 %id)
DB072323 testis .a 527 to 1060 2 to 538   tiling clone, capped   537/537
(100 %)
3 diff
(99.5 %id)
FN081994 breast carcinoma .a 884 to 981 1 to 98       98/98
(100 %)
0 diff
(100 %id)
BF368760 placenta_normal .a 1253 to 1728 1 to 474       474/474
(100 %)
17 diff
(96.5 %id)
BP240717 Liver .a 1273 to 1775 1 to 503       503/569
(88 %)
11 diff
(98.1 %id)
CD689800 normal nasopharynx .a 1281 to 1855 12 to 586       575/586
(98 %)
7 diff
(98.9 %id)
EH346064   .a 1562 to 1628 1 to 68       68/71
(95 %)
2 diff
(97.2 %id)
BM787594 stomach .a 1614 to 2305 1 to 692   tiling clone,   692/692
(100 %)
0 diff
(100 %id)
D82258   .a 1706 to 1857 11 to 160       150/169
(88 %)
14 diff
(91.8 %id)
BP354287   .a 1965 to 2545 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BX507603   .a 2060 to 2622 1 to 563       563/563
(100 %)
1 diff
(99.9 %id)
BI007435 kidney_tumor .a 2164 to 2542 379 to 1       379/379
(100 %)
0 diff
(100 %id)
AA244450   .a 2313 to 2699 1 to 388       388/389
(99 %)
9 diff
(97.7 %id)
BM718383 eye, fetal eye .a 2339 to 2986 1 to 648     Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 648/648
(100 %)
1 diff
(99.9 %id)
BU198103   .a 2351 to 2976 1 to 625       625/627
(99 %)
10 diff
(98.5 %id)
BF362326 nervous_normal .a 2362 to 2877 66 to 582       517/582
(88 %)
7 diff
(98.8 %id)
AL048872 testis .a 2705 to 3146 1 to 443       443/443
(100 %)
5 diff
(98.9 %id)
BF328328 breast_normal .a 2904 to 3213 346 to 37       310/379
(81 %)
0 diff
(100 %id)
AA281306 germinal center B cell .a 2904 to 3358 1 to 455       455/455
(100 %)
0 diff
(100 %id)
DN918376   .a 2906 to 3594 1 to 685       685/691
(99 %)
10 diff
(98.6 %id)
EH340678   .a 2975 to 3044 1 to 70       70/70
(100 %)
0 diff
(100 %id)
BF749401 breast_normal .a 3017 to 3212 1 to 196       196/196
(100 %)
2 diff
(99.0 %id)
DW416972 Liver .a 3106 to 3395 18 to 307       290/307
(94 %)
6 diff
(98.1 %id)
BM683441 eye, fetal eye .a 3165 to 3924 753 to 2   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 752/753
(99 %)
8 diff
(99.0 %id)
BM905228 melanotic melanoma, skin .a 3209 to 4222 1 to 1018   tiling clone,   1018/1018
(100 %)
10 diff
(99.1 %id)
FN126960 breast carcinoma .a 3238 to 3324 87 to 1     Submitted on the opposite strand 87/91
(95 %)
0 diff
(100 %id)
AW299294 Kidney .a 3265 to 3907 643 to 1       643/643
(100 %)
1 diff
(99.9 %id)
BM680144 eye, fetal eye .a 3266 to 3918 651 to 1       651/651
(100 %)
0 diff
(100 %id)
FN177409 breast carcinoma .a 3281 to 3355 1 to 72       72/72
(100 %)
5 diff
(93.1 %id)
AW299292 Kidney .a 3389 to 3907 519 to 1       519/519
(100 %)
2 diff
(99.7 %id)
AI341229 pooled germ cell tumors .a 3396 to 3906 511 to 1       511/511
(100 %)
0 diff
(100 %id)
AI656399 pooled germ cell tumors .a 3402 to 3910 510 to 2       509/510
(99 %)
0 diff
(100 %id)
DW425941 Liver .a 3462 to 3735 12 to 284       273/284
(96 %)
7 diff
(97.6 %id)
AW182541 pooled .a 3489 to 3903 415 to 1       415/415
(100 %)
2 diff
(99.6 %id)
AA937292 pooled .a 3550 to 3903 354 to 1       354/354
(100 %)
0 diff
(100 %id)
AA244381   .a 3561 to 3910 352 to 3       350/352
(99 %)
0 diff
(100 %id)
AI001846 pooled germ cell tumors .a 3563 to 3907 345 to 1       345/345
(100 %)
0 diff
(100 %id)
AA281257 germinal center B cell .a 3574 to 3912 339 to 1       339/339
(100 %)
0 diff
(100 %id)
DW446530 Liver .a 3687 to 3888 16 to 216       201/216
(93 %)
8 diff
(96.3 %id)
DA448415 tongue, tumor tissue .a 4072 to 4626 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
CK023727 brain/CNS, Human Brain - Cerebellar Cortex .a 4074 to 4702 1 to 617       617/662
(93 %)
16 diff
(97.6 %id)
BP361786 thalamus .a 4419 to 5004 1 to 586       586/587
(99 %)
1 diff
(99.9 %id)
BQ380429 uterus_tumor .a 4444 to 4694 252 to 1       252/255
(98 %)
2 diff
(99.3 %id)
BQ310440 breast .a 4511 to 5093 1 to 579       582/582
(100 %)
7 diff
(98.8 %id)
BQ310338 breast .a 4513 to 5115 17 to 618       602/621
(96 %)
19 diff
(97.0 %id)
CD557822 testis .a 4602 to 5455 45 to 901       857/901
(95 %)
12 diff
(98.7 %id)
DA476980   .a 4676 to 5237 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA773218 brain .a 4768 to 5302 2 to 536   capped   535/535
(100 %)
0 diff
(100 %id)
BX280772 lymph, lymphoma, cell line .a 4787 to 5263 1 to 477       477/477
(100 %)
0 diff
(100 %id)
BC048310 Lymph, lymphoma .a 4787 to 6621 1 to 1835   available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 1835/1836
(99 %)
5 diff
(99.8 %id)
BG176898 lymph, lymphoma, cell line .a 4787 to 5456 1 to 680   available from MGC,   680/973
(69 %)
21 diff
(97.9 %id)
BQ310577 breast .a 4897 to 5450 552 to 1       552/556
(99 %)
5 diff
(99.2 %id)
AA732652 germinal center B cell .a 5111 to 5556 448 to 3       446/448
(99 %)
0 diff
(100 %id)
BE005455 breast_normal .a 5128 to 5537 411 to 1     Submitted on the opposite strand 411/411
(100 %)
5 diff
(98.8 %id)
CN422363 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 5137 to 5855 1 to 719       719/719
(100 %)
5 diff
(99.4 %id)
DA696401   .a 5185 to 5765 2 to 585   capped   584/584
(100 %)
3 diff
(99.5 %id)
BM839648 Ascites, stomach .a 5335 to 5811 1 to 477       477/477
(100 %)
2 diff
(99.6 %id)
CN422365 embryonic stem cells, cell lines H1, H7, andH9 .a 5372 to 5996 1 to 625       625/625
(100 %)
1 diff
(99.9 %id)
BI261282 cervical carcinoma cell line, cervix .a 5405 to 6146 20 to 783   available from MGC,   744/790
(94 %)
39 diff
(95.1 %id)
BC033619 Cervix, carcinoma .a 5414 to 9767 12 to 4366   tiling clone, available from MGC, AAA   4355/4355
(100 %)
1 diff
(100.0 %id)
FN133679 breast carcinoma .a 5648 to 5751 107 to 3     Submitted on the opposite strand 105/107
(98 %)
0 diff
(100 %id)
BE929378 placenta_normal .a 5797 to 5998 209 to 7       203/222
(91 %)
1 diff
(99.6 %id)
AL048873 testis .a 5853 to 6594 739 to 2       738/740
(99 %)
6 diff
(99.2 %id)
BM721825 eye, fetal eye .a 5894 to 6533 1 to 641     Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 641/641
(100 %)
3 diff
(99.6 %id)
BM693887 eye, lens .a 5927 to 6585 1 to 659     Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 659/659
(100 %)
0 diff
(100 %id)
BQ777387 Pancreas, Purified pancreatic islet .a 5928 to 6359 47 to 478       432/478
(90 %)
6 diff
(98.8 %id)
DB083373 testis .a 5981 to 6535 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
AW517039 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 6071 to 6607 537 to 1       537/537
(100 %)
0 diff
(100 %id)
DA316541 hippocampus .a 6096 to 6641 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DW430898 Liver .a 6236 to 6496 11 to 271       261/271
(96 %)
6 diff
(97.8 %id)
CF135298 lymph .a 6295 to 6814 1 to 521       521/523
(99 %)
11 diff
(97.9 %id)
TI_154163510   .a 6302 to 7128 74 to 908       835/1193
(69 %)
46 diff
(96.2 %id)
AW263486 brain, three pooled meningiomas .a 6363 to 6602 240 to 1       240/241
(99 %)
6 diff
(97.6 %id)
AI267691 brain, frontal lobe (see description) .a 6403 to 6577 216 to 42   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 175/216
(81 %)
2 diff
(99.1 %id)
CN422360 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 6422 to 7108 1 to 687       687/687
(100 %)
1 diff
(99.9 %id)
DW464599 Liver .a 6471 to 6556 17 to 102       86/102
(84 %)
6 diff
(94.2 %id)
CA398056 eye, RPE/choroid .a 6552 to 7114 1 to 563     Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 563/563
(100 %)
0 diff
(100 %id)
BU740024 eye, fetal eye .a 6616 to 7163 552 to 5   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 548/552
(99 %)
0 diff
(100 %id)
BM670948 eye, lens .a 6618 to 7159 542 to 2   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 541/542
(99 %)
1 diff
(99.9 %id)
DB293290   .a 6778 to 7465 2 to 690   capped   689/689
(100 %)
6 diff
(99.2 %id)
BQ226563 embryonal carcinoma, cell line, testis .a 6779 to 7163 1 to 385   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 385/391
(98 %)
5 diff
(98.8 %id)
AI018580 pooled .a 6799 to 7144 346 to 1       346/346
(100 %)
0 diff
(100 %id)
AI474035 Kidney .a 6820 to 7151 332 to 1       332/332
(100 %)
3 diff
(99.1 %id)
AW973530   .a 6903 to 7140 238 to 1     Submitted on the opposite strand 238/343
(69 %)
0 diff
(100 %id)
AA576746 colon, colon tumor RER+ .a 6936 to 7140 205 to 1       205/205
(100 %)
0 diff
(100 %id)
AI758286 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 6941 to 7173 234 to 1       234/234
(100 %)
1 diff
(99.6 %id)
BF349703 head_neck .a 6983 to 7294 313 to 2       312/313
(99 %)
0 diff
(100 %id)
FN163442 breast carcinoma .a 7084 to 7146 66 to 4     Submitted on the opposite strand 63/70
(90 %)
0 diff
(100 %id)
BU192534 epithelioid carcinoma, Pancreas .a 7166 to 8010 1 to 859       859/906
(94 %)
21 diff
(97.7 %id)
CD655540 Embryonic Stem cells .a 7208 to 7971 31 to 789       759/809
(93 %)
6 diff
(99.3 %id)
BQ366694 placenta_normal .a 7312 to 7864 592 to 33       560/592
(94 %)
0 diff
(100 %id)
DB069408 testis .a 7365 to 7910 2 to 548   capped   547/547
(100 %)
2 diff
(99.7 %id)
DA642965 Liver .a 7403 to 7968 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
AL079837 testis .a 7577 to 7989 1 to 413       413/413
(100 %)
1 diff
(99.8 %id)
BE926878 breast .a 7616 to 8081 39 to 506       468/509
(91 %)
4 diff
(99.3 %id)
DB035712 testis .a 7767 to 8344 2 to 580   capped   579/579
(100 %)
4 diff
(99.4 %id)
BU618791 Cell Line, Chondrosarcoma .a 7850 to 8620 765 to 2   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 764/765
(99 %)
0 diff
(100 %id)
CR618030 Neuroblastoma Cot 10-normalized .a 7910 to 9730 1 to 1821   tiling clone,   1821/1821
(100 %)
0 diff
(100 %id)
AL521318 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 7911 to 8835 1 to 925   fully sequenced,   925/925
(100 %)
6 diff
(99.4 %id)
AW152075 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 7989 to 8595 608 to 1       608/615
(98 %)
3 diff
(99.6 %id)
AI902716 breast .a 7990 to 8500 510 to 1       510/510
(100 %)
5 diff
(99.1 %id)
AU127384   .a 7992 to 8555 2 to 567   capped   566/566
(100 %)
15 diff
(97.4 %id)
BI254325 cervical carcinoma cell line, cervix .a 8102 to 8959 1 to 857       857/857
(100 %)
21 diff
(97.6 %id)
CA389797 eye, RPE/choroid .a 8149 to 8682 1 to 534       534/534
(100 %)
2 diff
(99.7 %id)
AA778059 heart .a 8163 to 8604 442 to 1       442/442
(100 %)
0 diff
(100 %id)
BP276748 Kidney .a 8208 to 8790 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BP370242 testis .a 8208 to 8789 1 to 582       582/582
(100 %)
4 diff
(99.4 %id)
DA348792 substantia nigra .a 8253 to 8739 2 to 488   capped   487/487
(100 %)
0 diff
(100 %id)
BP369261 testis .a 8273 to 8848 1 to 576       576/576
(100 %)
0 diff
(100 %id)
CN422362 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 8383 to 8907 1 to 525       525/525
(100 %)
0 diff
(100 %id)
BI043408 ovary .a 8455 to 8988 543 to 12       532/543
(97 %)
10 diff
(98.2 %id)
CB133971 Liver .a 8464 to 9009 1 to 546       546/546
(100 %)
0 diff
(100 %id)
BI044114 ovary .a 8473 to 8988 529 to 14       516/529
(97 %)
7 diff
(98.7 %id)
DA398284 thalamus .a 8494 to 9059 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA808382 brain .a 8502 to 9071 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
BI043407 ovary .a 8504 to 8988 487 to 4       484/487
(99 %)
15 diff
(97.0 %id)
DA555436   .a 8530 to 9088 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
BU568845 testis .a 8606 to 9261 1 to 670       670/866
(77 %)
23 diff
(97.4 %id)
AW602014 breast .a 8646 to 8890 1 to 245       245/245
(100 %)
7 diff
(97.2 %id)
DA808094 brain .a 8651 to 9242 2 to 593   capped   592/592
(100 %)
1 diff
(99.9 %id)
BU171333 leiomyosarcoma, uterus .a 8705 to 9564 1 to 868       868/887
(97 %)
21 diff
(97.7 %id)
CF137072 lymph .a 8711 to 9039 1 to 329       329/329
(100 %)
4 diff
(98.8 %id)
TI_154166413   .a 8717 to 9204 79 to 564       486/486
(100 %)
25 diff
(94.9 %id)
DB078885 testis .a 8731 to 9304 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
AL561979 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 8805 to 9730 928 to 1   fully sequenced,   928/928
(100 %)
4 diff
(99.6 %id)
DA770444 brain .a 8851 to 9410 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
DA447290 tongue, tumor tissue .a 8853 to 9413 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
CN422361 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 8872 to 9529 9 to 665       657/665
(98 %)
8 diff
(98.8 %id)
CA395339 eye, RPE/choroid .a 8883 to 9245 1 to 363       363/363
(100 %)
3 diff
(99.2 %id)
BI062691 uterus_tumor .a 8893 to 9370 479 to 1       479/505
(94 %)
1 diff
(99.9 %id)
BP290359 lung .a 8930 to 9511 1 to 582       582/582
(100 %)
9 diff
(98.5 %id)
TI_149301590   .a 9024 to 9767 816 to 84   AAA   733/908
(80 %)
14 diff
(98.5 %id)
AI653027 pooled germ cell tumors .a 9098 to 9774 681 to 5       677/681
(99 %)
3 diff
(99.6 %id)
BM980011 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 9098 to 9767 686 to 19   AAA   668/668
(100 %)
2 diff
(99.8 %id)
BF061944 pooled germ cell tumors .a 9106 to 9774 674 to 5       670/675
(99 %)
3 diff
(99.6 %id)
DA442375 tongue, tumor tissue .a 9109 to 9692 2 to 585   capped   584/584
(100 %)
0 diff
(100 %id)
BX499920 Liver .a 9143 to 9729 1 to 587       587/587
(100 %)
0 diff
(100 %id)
FN143960 breast carcinoma .a 9152 to 9231 1 to 81       81/82
(98 %)
2 diff
(97.6 %id)
DA733056   .a 9152 to 9851 2 to 700   capped   699/699
(100 %)
10 diff
(98.6 %id)
AW025639 pooled germ cell tumors .a 9169 to 9774 623 to 5       617/643
(95 %)
27 diff
(95.9 %id)
AW613146 colon, moderately-differentiated adenocarcinoma .a 9185 to 9767 584 to 1       584/584
(100 %)
1 diff
(99.9 %id)
AI654480 pooled germ cell tumors .a 9188 to 9728 541 to 1       541/541
(100 %)
14 diff
(97.5 %id)
DB175634 kidney, tumor tissue .a 9200 to 9766 2 to 570   capped   569/569
(100 %)
3 diff
(99.5 %id)
AL700483 human skeletal muscle .a 9238 to 9747 1 to 510       510/510
(100 %)
7 diff
(98.7 %id)
BP371467 testis .a 9247 to 9767 1 to 521   AAA   521/521
(100 %)
0 diff
(100 %id)
DB383226   .a 9293 to 9767 478 to 1       478/557
(85 %)
17 diff
(97.0 %id)
DB522285 testis .a 9311 to 9773 1 to 463     Submitted on the opposite strand 463/463
(100 %)
0 diff
(100 %id)
BE001568 breast_normal .a 9337 to 9518 8 to 188       181/196
(92 %)
7 diff
(96.5 %id)
DA510702 brain .a 9339 to 9744 2 to 408   capped   407/407
(100 %)
2 diff
(99.6 %id)
AL119214 amygdala .a 9352 to 9618 1 to 268       267/271
(98 %)
16 diff
(94.1 %id)
DW436547 Liver .a 9544 to 9771 17 to 245       229/252
(90 %)
9 diff
(96.5 %id)
DA491979 brain .a 9544 to 10095 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DB169226 kidney, tumor tissue .a 9567 to 10139 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA747613   .a 9639 to 10195 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA371001 thalamus .a 9686 to 10229 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
BX956411   .a 9707 to 10188 1 to 482       482/482
(100 %)
1 diff
(99.8 %id)
BP221365 colon .a 9751 to 10313 1 to 563       563/563
(100 %)
2 diff
(99.7 %id)
BP367872 thymus .a 9773 to 10354 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
DN916006   .a 9917 to 10525 1 to 609       609/609
(100 %)
17 diff
(97.3 %id)
BU176159 eye, retinoblastoma .a 9970 to 10851 1 to 887       887/888
(99 %)
9 diff
(99.0 %id)
AU133409   .a 10055 to 10914 2 to 862   capped   861/861
(100 %)
7 diff
(99.2 %id)
AU133421   .a 10055 to 10643 2 to 591   capped   590/590
(100 %)
1 diff
(99.9 %id)
CD557220 testis .a 10128 to 10858 1 to 738       738/830
(88 %)
13 diff
(98.5 %id)
CN422364 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 10151 to 10691 1 to 541       541/541
(100 %)
0 diff
(100 %id)
AV695353 hepatocellular carcinoma .a 10154 to 10800 1 to 645       645/744
(86 %)
15 diff
(98.0 %id)
AA808838 Kidney, kidney tumor .a 10155 to 10350 1 to 196       196/196
(100 %)
0 diff
(100 %id)
AA689230 normal prostate, Prostate .a 10183 to 10529 1 to 347       347/347
(100 %)
1 diff
(99.8 %id)
Z46048 brain, total brain .a 10217 to 10575 1 to 359       359/359
(100 %)
1 diff
(99.8 %id)
R34531.
matches multiple genes
whole brain .a 10260 to 10625 1 to 376     also hits gene ICMT 376/454
(82 %)
11 diff
(97.6 %id)
BP220973 colon .a 10262 to 10820 1 to 559       559/559
(100 %)
14 diff
(97.5 %id)
AA069534 pineal gland .a 10264 to 10497 1 to 234     Submitted on the opposite strand 234/234
(100 %)
0 diff
(100 %id)
AL044287 testis .a 10432 to 10992 1 to 560       560/560
(100 %)
1 diff
(99.9 %id)
AI983097 brain, three pooled meningiomas .a 10464 to 10869 16 to 422     Submitted on the opposite strand 407/422
(96 %)
6 diff
(98.6 %id)
AI123066 pooled .a 10478 to 10754 277 to 1       277/277
(100 %)
0 diff
(100 %id)
CD171841 testis .a 10554 to 11227 1 to 677       677/881
(76 %)
13 diff
(98.6 %id)
BG687508 lung, mucoepidermoid carcinoma .a 10583 to 11349 1 to 775       775/883
(87 %)
25 diff
(97.2 %id)
BQ428044 leiomyosarcoma, uterus .a 10605 to 11472 1 to 873       873/873
(100 %)
18 diff
(98.0 %id)
BF694814 muscle (skeletal) .a 10611 to 11254 1 to 639       639/642
(99 %)
7 diff
(99.0 %id)
BQ718502 sympathetic trunk .a 10614 to 11428 1 to 819       819/938
(87 %)
11 diff
(98.9 %id)
FN108857 breast carcinoma .a 10695 to 10758 1 to 64       64/65
(98 %)
3 diff
(95.4 %id)
FN167264 breast carcinoma .a 10720 to 10804 1 to 84       84/84
(100 %)
3 diff
(96.5 %id)
BG248839 hypernephroma, cell line, Kidney .a 10740 to 11495 1 to 749       749/921
(81 %)
22 diff
(97.7 %id)
BP211947 cerebrum .a 10813 to 11396 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
FN111573 breast carcinoma .a 10822 to 10918 98 to 5     Submitted on the opposite strand 94/106
(88 %)
0 diff
(100 %id)
BQ884222 sciatic nerve .a 10834 to 11487 1 to 667       667/929
(71 %)
19 diff
(98.0 %id)
DA522244 brain .a 10910 to 11460 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
BU153479 embryonal carcinoma, cell line, testis .a 10919 to 11805 1 to 885       885/886
(99 %)
7 diff
(99.3 %id)
W79116 heart .a 11007 to 11442 1 to 438       438/440
(99 %)
8 diff
(98.2 %id)
BG009597 placenta_normal .a 11012 to 11463 96 to 550       455/550
(82 %)
6 diff
(99.0 %id)
BX283760 choriocarcinoma, placenta .a 11021 to 11536 1 to 516       516/516
(100 %)
1 diff
(99.9 %id)
BE410150 choriocarcinoma, placenta .a 11022 to 11836 14 to 822       809/860
(94 %)
14 diff
(98.4 %id)
BI838792 pooled pancreas and spleen .a 11023 to 11804 1 to 811       811/811
(100 %)
67 diff
(91.8 %id)
TI_57162388   .a 11023 to 11804 1 to 811       811/811
(100 %)
67 diff
(91.8 %id)
AW276787 ovary, papillary serous ovarian metastasis .a 11026 to 11448 1 to 424     Submitted on the opposite strand 424/424
(100 %)
7 diff
(98.4 %id)
BG218211   .a 11074 to 11322 7 to 257       251/258
(97 %)
14 diff
(94.6 %id)
TI_154051930   .a 11074 to 11975 935 to 42       894/1059
(84 %)
0 diff
(100 %id)
AA394297   .a 11076 to 11562 1 to 487       487/487
(100 %)
0 diff
(100 %id)
CA414893 Chondrosarcoma Grade II, Left Pelvis .a 11182 to 11955 791 to 18   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 774/774
(100 %)
6 diff
(99.3 %id)
CA314773 Human Lung Epithelial cells, lung .a 11212 to 11955 759 to 17   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 743/743
(100 %)
2 diff
(99.8 %id)
TI_149285483   .a 11267 to 12143 959 to 95   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 865/1112
(77 %)
26 diff
(97.7 %id)
FN169250 breast carcinoma .a 11294 to 11402 109 to 1     Submitted on the opposite strand 109/110
(99 %)
8 diff
(92.8 %id)
AW768744 colon, moderately-differentiated adenocarcinoma .a 11294 to 11710 24 to 440     Submitted on the opposite strand 417/440
(94 %)
7 diff
(98.5 %id)
BU149693 dorsal root ganglia .a 11295 to 12196 1 to 912       912/923
(98 %)
24 diff
(97.4 %id)
DA306065 hippocampus .a 11323 to 11912 2 to 592   capped   591/591
(100 %)
1 diff
(99.9 %id)
BP333802 salivary gland .a 11323 to 11908 1 to 586       586/586
(100 %)
2 diff
(99.7 %id)
FN146753 breast carcinoma .a 11347 to 11446 99 to 1     Submitted on the opposite strand 99/108
(91 %)
1 diff
(99.1 %id)
AU154750   .a 11404 to 11953 550 to 1       550/553
(99 %)
6 diff
(99.0 %id)
AW975803   .a 11416 to 12142 729 to 1     Submitted on the opposite strand 729/777
(93 %)
4 diff
(99.5 %id)
BI835181 pooled pancreas and spleen .a 11426 to 12119 1 to 692       692/694
(99 %)
14 diff
(98.0 %id)
TI_57167056   .a 11427 to 12119 33 to 723       691/725
(95 %)
14 diff
(98.1 %id)
CA398055 eye, RPE/choroid .a 11439 to 12143 722 to 18   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 705/705
(100 %)
0 diff
(100 %id)
DB364800   .a 11449 to 11955 504 to 1       504/547
(92 %)
10 diff
(98.2 %id)
TI_159715172   .a 11459 to 11961 593 to 91   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 503/1073
(46 %)
0 diff
(100 %id)
CB306690 Human Lung Epithelial cells, lung .a 11459 to 11961 515 to 13   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 503/512
(98 %)
0 diff
(100 %id)
BP377841 uterus .a 11462 to 12044 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
AW074050 2 pooled high-grade transitional celltumors, genitourinary tract .a 11475 to 11956 482 to 1       482/482
(100 %)
1 diff
(99.8 %id)
AW614160 Kidney .a 11477 to 11953 477 to 1       477/477
(100 %)
0 diff
(100 %id)
BM984904 lung .a 11481 to 12143 681 to 19   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 663/663
(100 %)
1 diff
(99.9 %id)
AU149987   .a 11482 to 11955 475 to 1       475/490
(96 %)
11 diff
(97.8 %id)
AA278795.
matches multiple genes
germinal center B cell .a 11496 to 11927 1 to 432     also hits gene ARV1 432/432
(100 %)
0 diff
(100 %id)
AW451943   .a 11511 to 11955 460 to 16   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 445/445
(100 %)
0 diff
(100 %id)
AA689507 normal prostate, Prostate .a 11512 to 11953 443 to 1       443/443
(100 %)
1 diff
(99.8 %id)
AW513746 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 11514 to 11957 444 to 1       444/444
(100 %)
2 diff
(99.6 %id)
W79832 heart .a 11516 to 11953 440 to 1       440/441
(99 %)
2 diff
(99.6 %id)
AW026792 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 11523 to 11959 437 to 1       437/437
(100 %)
0 diff
(100 %id)
AA922059 pooled .a 11528 to 11954 429 to 3       427/429
(99 %)
0 diff
(100 %id)
BF680367 Prostate .a 11532 to 12214 1 to 678       678/878
(77 %)
23 diff
(97.4 %id)
AL711244 human skeletal muscle .a 11534 to 12225 1 to 691       691/691
(100 %)
4 diff
(99.5 %id)
BG716561 brain, hypothalamus .a 11534 to 11977 1 to 444       444/448
(99 %)
10 diff
(97.8 %id)
BM762485 lymph node, stomach .a 11548 to 12035 84 to 571       488/571
(85 %)
6 diff
(99.0 %id)
R25352 placenta .a 11556 to 11894 1 to 350       350/353
(99 %)
12 diff
(96.7 %id)
AA757551 pineal gland .a 11558 to 11953 396 to 1       396/396
(100 %)
0 diff
(100 %id)
R49066 whole brain .a 11566 to 11960 405 to 3       403/499
(80 %)
0 diff
(100 %id)
AI767505 Kidney .a 11569 to 12143 576 to 1       576/576
(100 %)
1 diff
(99.9 %id)
BP292835 lung .a 11576 to 12161 1 to 588       588/588
(100 %)
3 diff
(99.5 %id)
AW297766   .a 11611 to 12143 550 to 18   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 533/533
(100 %)
1 diff
(99.9 %id)
AI760185 pooled .a 11627 to 12142 516 to 1       516/516
(100 %)
1 diff
(99.9 %id)
T78995 liver and spleen .a 11631 to 12068 1 to 446       446/529
(84 %)
14 diff
(97.4 %id)
AA412149   .a 11631 to 11958 329 to 1       329/329
(100 %)
1 diff
(99.7 %id)
FN099056 breast carcinoma .a 11632 to 11713 83 to 4     Submitted on the opposite strand 80/84
(95 %)
0 diff
(100 %id)
H91438 liver and spleen .a 11632 to 11961 1 to 332       332/332
(100 %)
3 diff
(99.1 %id)
AA766306 germinal center B cell .a 11645 to 12152 509 to 1       509/509
(100 %)
4 diff
(99.3 %id)
Z41658 brain, total brain .a 11651 to 11953 303 to 1       303/303
(100 %)
1 diff
(99.7 %id)
AA721747 germinal center B cell .a 11656 to 11960 309 to 5       305/309
(98 %)
0 diff
(100 %id)
AI092924 heart .a 11663 to 12143 481 to 1       481/481
(100 %)
0 diff
(100 %id)
BG105688 adrenal cortex carcinoma, cell line, adrenal gland .a 11697 to 12158 37 to 499       463/503
(92 %)
15 diff
(97.1 %id)
AI027099 parathyroid gland, parathyroid tumor .a 11702 to 12149 448 to 1       448/448
(100 %)
0 diff
(100 %id)
DR762512 embryonic stem .a 11703 to 12540 1 to 840   tiling clone,   840/840
(100 %)
1 diff
(99.9 %id)
R68430 placenta .a 11734 to 12091 1 to 369       369/369
(100 %)
14 diff
(96.3 %id)
AI206601   .a 11753 to 12146 394 to 1       394/394
(100 %)
0 diff
(100 %id)
AA813995 germinal center B cell .a 11769 to 12152 384 to 1       384/384
(100 %)
1 diff
(99.8 %id)
AW450169   .a 11778 to 12143 383 to 18   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 366/373
(98 %)
0 diff
(100 %id)
AL042348 testis .a 11796 to 12385 1 to 587       587/587
(100 %)
10 diff
(98.3 %id)
FN103262 breast carcinoma .a 11801 to 11928 123 to 1     Submitted on the opposite strand 123/123
(100 %)
4 diff
(96.8 %id)
AA731014 germinal center B cell .a 11811 to 12152 342 to 1       342/342
(100 %)
0 diff
(100 %id)
DN998402 bone marrow .a 11817 to 12462 1 to 647       647/647
(100 %)
5 diff
(99.3 %id)
BM754221 Ascites, stomach .a 11829 to 12392 1 to 563       563/563
(100 %)
2 diff
(99.7 %id)
AW469775 pooled .a 11835 to 12146 312 to 1       312/312
(100 %)
0 diff
(100 %id)
BF438913 pooled .a 11841 to 12149 309 to 1       309/309
(100 %)
0 diff
(100 %id)
BM739875 Ascites, stomach .a 11858 to 12373 1 to 516   tiling clone,   516/516
(100 %)
2 diff
(99.7 %id)
FN138676 breast carcinoma .a 11872 to 11990 113 to 1     Submitted on the opposite strand 113/121
(93 %)
5 diff
(95.9 %id)
T78939 liver and spleen .a 12654 to 13046 403 to 1   tiling clone,   403/403
(100 %)
16 diff
(96.1 %id)
H91332 liver and spleen .a 12788 to 13046 262 to 1       262/263
(99 %)
5 diff
(98.1 %id)
R68431 placenta .a 13037 to 13448 420 to 1   tiling clone,   420/425
(98 %)
11 diff
(97.5 %id)
DA494109 brain .b 1 to 565 2 to 566   tiling clone, capped   565/565
(100 %)
1 diff
(99.9 %id)
AK026986   .b 1146 to 4375 1 to 3228   tiling clone, available from FLJ, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 3228/3241
(99 %)
4 diff
(99.9 %id)
DB315551 brain .b 2775 to 3313 541 to 1       541/541
(100 %)
3 diff
(99.5 %id)
DB072537 testis .b 3457 to 3999 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
BC017847 skeletal muscle .c 1 to 1332 1 to 1332   tiling clone, available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 1332/1344
(99 %)
8 diff
(99.5 %id)
BF575121 muscle (skeletal) .c 1 to 650 1 to 653   available from MGC,   653/658
(99 %)
6 diff
(99.1 %id)
AB007949 brain .c 48 to 6096 63 to 6111   tiling clone, available from KIAA,   6049/6111
(98 %)
9 diff
(99.9 %id)
AU123403   .c 6036 to 6668 2 to 637   tiling clone, capped   636/636
(100 %)
4 diff
(99.4 %id)
BM738891 Ascites, stomach .c 6048 to 6539 1 to 492       492/492
(100 %)
3 diff
(99.4 %id)
BE890441 melanotic melanoma, skin .c 6095 to 6861 1 to 759       759/776
(97 %)
30 diff
(96.2 %id)
AA278600 germinal center B cell .c 6140 to 6283 145 to 1       145/146
(99 %)
6 diff
(95.9 %id)
FN050666 breast carcinoma .c 6198 to 6283 1 to 86       86/88
(97 %)
1 diff
(98.9 %id)
AU185622 skin .c 6229 to 6526 298 to 1       298/298
(100 %)
0 diff
(100 %id)
AA361014   .c 6304 to 6493 1 to 190       190/191
(99 %)
1 diff
(99.5 %id)
FN049053 breast carcinoma .c 6330 to 6383 1 to 54       54/55
(98 %)
1 diff
(98.2 %id)
AW368993 head_neck .c 6380 to 7032 1 to 650       650/676
(96 %)
14 diff
(98.0 %id)
AY007149   .c 6442 to 7589 1 to 1148   tiling clone, AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 1148/1148
(100 %)
1 diff
(100.0 %id)
CB853210 Human Lung Epithelial cells, lung .c 6475 to 6924 452 to 3       450/461
(97 %)
0 diff
(100 %id)
BF888892 testis_normal .c 6504 to 6688 1 to 188       188/188
(100 %)
10 diff
(94.7 %id)
R57916   .c 6516 to 6687 1 to 172       172/172
(100 %)
3 diff
(98.3 %id)
AA353814   .c 6591 to 6840 1 to 251       251/251
(100 %)
1 diff
(99.7 %id)
AW957542   .c 6592 to 7195 1 to 602   tiling clone,   602/603
(99 %)
7 diff
(98.9 %id)
AA040922 uterus .c 6640 to 6780 1 to 142       142/146
(97 %)
5 diff
(96.6 %id)
BE775143 uterus .c 6684 to 7146 7 to 468       462/468
(98 %)
6 diff
(98.8 %id)
BE775269 uterus .c 6684 to 7146 7 to 468       462/468
(98 %)
6 diff
(98.8 %id)
AW803578 uterus .c 6698 to 7190 1 to 493       493/493
(100 %)
1 diff
(99.8 %id)
AW803705 uterus .c 6698 to 6863 166 to 1       166/166
(100 %)
2 diff
(98.8 %id)
BE775145 uterus .c 6703 to 7218 516 to 1       516/516
(100 %)
5 diff
(99.1 %id)
BE775271 uterus .c 6703 to 7218 516 to 1       516/516
(100 %)
5 diff
(99.1 %id)
R80985 placenta .c 6723 to 7173 1 to 453       453/453
(100 %)
14 diff
(97.0 %id)
BM931399 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 6757 to 7458 1 to 701       701/703
(99 %)
5 diff
(99.3 %id)
BQ772066 Chondrosarcoma Grade II, Left Pelvis .c 6824 to 7589 780 to 19   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 762/762
(100 %)
5 diff
(99.4 %id)
BQ574614 Chondrosarcoma Grade II, Left Pelvis .c 6839 to 7589 769 to 19   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 751/751
(100 %)
0 diff
(100 %id)
AW803621 uterus .c 6861 to 7218 358 to 1       358/358
(100 %)
2 diff
(99.5 %id)
CA443395 Fibrosarcoma .c 6865 to 7589 738 to 19   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 720/722
(99 %)
8 diff
(98.9 %id)
TI_149283544   .c 6902 to 7589 765 to 78   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 688/688
(100 %)
2 diff
(99.8 %id)
H12655 placenta .c 6909 to 7266 1 to 371   fully sequenced,   371/371
(100 %)
13 diff
(96.5 %id)
BU680193 lung, Primary Lung Epithelial Cells .c 6923 to 7589 685 to 19   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 667/667
(100 %)
1 diff
(99.9 %id)
BQ014408 Chondrosarcoma, Left Pubic Bone .c 6928 to 7589 680 to 19   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 662/662
(100 %)
0 diff
(100 %id)
FN152376 breast carcinoma .c 6934 to 7037 1 to 101       101/103
(98 %)
6 diff
(94.2 %id)
BF378799 uterus .c 6967 to 7122 1 to 156       156/156
(100 %)
1 diff
(99.4 %id)
BQ022841 placenta .c 6990 to 7589 618 to 19   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 600/600
(100 %)
2 diff
(99.7 %id)
BE006123 breast_normal .c 6991 to 7480 10 to 498       489/502
(97 %)
7 diff
(98.7 %id)
BG026878 Bone, osteosarcoma, cell line .c 7009 to 7585 1 to 580       580/982
(59 %)
18 diff
(98.2 %id)
FN049877 breast carcinoma .c 7014 to 7129 1 to 120       120/120
(100 %)
4 diff
(96.7 %id)
BQ023401 placenta .c 7044 to 7589 564 to 19   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 546/550
(99 %)
0 diff
(100 %id)
AI041204   .c 7045 to 7591 548 to 2       547/548
(99 %)
0 diff
(100 %id)
AI638166 pooled germ cell tumors .c 7045 to 7589 560 to 16   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 545/545
(100 %)
0 diff
(100 %id)
AI478737 pooled .c 7065 to 7591 528 to 2       527/528
(99 %)
0 diff
(100 %id)
BE504727 pooled germ cell tumors .c 7071 to 7589 519 to 1       519/519
(100 %)
1 diff
(99.9 %id)
AI830441 Kidney .c 7080 to 7590 513 to 1       513/513
(100 %)
4 diff
(99.3 %id)
AI126299   .c 7096 to 7591 497 to 2   tiling clone,   496/497
(99 %)
0 diff
(100 %id)
AI799277 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .c 7110 to 7589 480 to 1       480/480
(100 %)
0 diff
(100 %id)
AI217176   .c 7112 to 7591 482 to 3       480/482
(99 %)
0 diff
(100 %id)
AI857759 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 7114 to 7591 479 to 1       479/479
(100 %)
4 diff
(99.2 %id)
CA432989 mixed .c 7118 to 7589 490 to 19   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 472/472
(100 %)
1 diff
(99.8 %id)
AA136171.
matches multiple genes
uterus .c 7122 to 7561 1 to 441     also hits gene ZNF638 441/441
(100 %)
1 diff
(99.8 %id)
AA993596   .c 7133 to 7591 460 to 2       459/460
(99 %)
0 diff
(100 %id)
BF057301 pooled germ cell tumors .c 7136 to 7591 456 to 1       456/456
(100 %)
1 diff
(99.8 %id)
AI620345 Prostate .c 7138 to 7589 452 to 1       452/452
(100 %)
0 diff
(100 %id)
AI381442 B-cell, chronic lymphotic leukemia .c 7139 to 7591 456 to 4       453/456
(99 %)
0 diff
(100 %id)
AW467616 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .c 7149 to 7589 441 to 1       441/441
(100 %)
0 diff
(100 %id)
AI827435 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 7155 to 7590 436 to 1       436/436
(100 %)
1 diff
(99.8 %id)
AA743334 germinal center B cell .c 7160 to 7589 442 to 13   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 430/430
(100 %)
0 diff
(100 %id)
AI138805   .c 7162 to 7591 432 to 3       430/432
(99 %)
0 diff
(100 %id)
AI285950 pooled .c 7162 to 7591 431 to 2       430/431
(99 %)
0 diff
(100 %id)
AI635387 pooled germ cell tumors .c 7162 to 7590 429 to 1       429/429
(100 %)
0 diff
(100 %id)
BE856706 pooled .c 7163 to 7589 443 to 17   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 427/427
(100 %)
0 diff
(100 %id)
AA664373 lung .c 7165 to 7591 427 to 1       427/427
(100 %)
0 diff
(100 %id)
AA976953 pooled germ cell tumors .c 7166 to 7589 425 to 1       425/425
(100 %)
1 diff
(99.8 %id)
AI827427 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 7169 to 7590 422 to 1       422/422
(100 %)
0 diff
(100 %id)
AI222122 pooled .c 7174 to 7590 417 to 1       417/417
(100 %)
0 diff
(100 %id)
AI015864   .c 7183 to 7589 419 to 13   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 407/407
(100 %)
0 diff
(100 %id)
AW195005 Kidney .c 7185 to 7591 410 to 4       407/410
(99 %)
0 diff
(100 %id)
AA843185 parathyroid gland, parathyroid tumor .c 7188 to 7589 419 to 18   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 402/403
(99 %)
0 diff
(100 %id)
AI685358 pooled .c 7192 to 7591 402 to 3       400/402
(99 %)
0 diff
(100 %id)
AW511065 pooled .c 7199 to 7591 394 to 2       393/394
(99 %)
0 diff
(100 %id)
AA040923 uterus .c 7201 to 7589 402 to 1       402/406
(99 %)
12 diff
(97.1 %id)
BF196075 Kidney .c 7213 to 7591 379 to 1       379/380
(99 %)
4 diff
(99.0 %id)
AW023027 cochlea, ear .c 7215 to 7590 11 to 387   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 377/387
(97 %)
6 diff
(98.5 %id)
BE897656 melanotic melanoma, skin .c 7216 to 7430 414 to 638       563/641
(87 %)
30 diff
(95.4 %id)
AW021642 cochlea, ear .c 7217 to 7589 1 to 373   fully sequenced, AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 373/373
(100 %)
5 diff
(98.7 %id)
AA056678 uterus .c 7224 to 7591 1 to 385   fully sequenced,   385/385
(100 %)
23 diff
(94.1 %id)
AA912496 pooled .c 7226 to 7591 368 to 3       366/368
(99 %)
0 diff
(100 %id)
AW665945 pooled .c 7231 to 7591 363 to 3       361/363
(99 %)
0 diff
(100 %id)
AW269181 Kidney .c 7233 to 7590 358 to 1       358/358
(100 %)
3 diff
(99.2 %id)
H12605 placenta .c 7236 to 7550 324 to 1   fully sequenced,   324/324
(100 %)
4 diff
(98.8 %id)
AA926963 pooled .c 7237 to 7591 361 to 7       355/361
(98 %)
0 diff
(100 %id)
FN116060 breast carcinoma .c 7243 to 7313 1 to 71       71/72
(98 %)
3 diff
(95.9 %id)
AI249890 lymph node, lymphoma, follicular mixed small and largecell .c 7247 to 7589 366 to 24   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 343/343
(100 %)
7 diff
(98.0 %id)
AA804916 germinal center B cell .c 7260 to 7590 337 to 7       331/337
(98 %)
0 diff
(100 %id)
BI492583 cochlea, ear .c 7262 to 7589 346 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 328/328
(100 %)
0 diff
(100 %id)
BF436561 breast, invasive ductal carcinoma, 3 pooled samples .c 7283 to 7589 328 to 22   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 307/307
(100 %)
0 diff
(100 %id)
AW071659 pooled germ cell tumors .c 7292 to 7589 326 to 29   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 298/298
(100 %)
9 diff
(97.0 %id)
AW135157   .c 7292 to 7589 315 to 18   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 298/298
(100 %)
0 diff
(100 %id)
AA056573 uterus .c 7308 to 7590 284 to 1   fully sequenced,   284/284
(100 %)
0 diff
(100 %id)
AA987389 Kidney, kidney tumor .c 7328 to 7589 262 to 1       262/262
(100 %)
1 diff
(99.7 %id)
AI538809 serous papillary carcinoma, high grade, 2pooled tumors, uterus .c 7329 to 7589 261 to 1       261/261
(100 %)
0 diff
(100 %id)
AW970477   .c 7393 to 7588 196 to 1     Submitted on the opposite strand 196/336
(58 %)
0 diff
(100 %id)
AI699602 pooled germ cell tumors .c 7409 to 7591 184 to 1       184/184
(100 %)
3 diff
(98.4 %id)
CN429635 embryonic stem cells, DMSO-treated H9 cellline .c 7410 to 7591 1 to 182       182/185
(98 %)
1 diff
(99.5 %id)
AA536104 colon .c 7427 to 7591 171 to 7       165/171
(96 %)
0 diff
(100 %id)
EH336766   .c 7511 to 7591 1 to 81       81/84
(96 %)
1 diff
(98.9 %id)
AK000704 ileal mucosa .d 1 to 3521 1 to 3519   tiling clone, available from FLJ, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 3519/3530
(99 %)
4 diff
(99.9 %id)
AW517052 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 3067 to 3524 458 to 1       458/496
(92 %)
34 diff
(93.2 %id)
CB048364 Prostate .d 3246 to 3687 14 to 455   tiling clone, fully sequenced, AAA   442/455
(97 %)
6 diff
(98.7 %id)
AA635523 normal prostate, Prostate .d 3340 to 3687 348 to 1       348/348
(100 %)
0 diff
(100 %id)
CB048363 Prostate .d 3395 to 3687 316 to 24   fully sequenced, AAA   293/293
(100 %)
0 diff
(100 %id)
BX641252   .d 3596 to 3902 1 to 307   tiling clone,   307/307
(100 %)
1 diff
(99.7 %id)
AK126046 testis .e 1 to 3549 1 to 3549 K225E tiling clone, available from FLJ,   3549/3549
(100 %)
2 diff
(100.0 %id)
DB087207 testis .e 2 to 565 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
AK022813   .e 1773 to 4496 1 to 2724   tiling clone, available from FLJ,   2724/2724
(100 %)
3 diff
(99.9 %id)
CB138775 Liver .e 3004 to 3613 1 to 610       610/610
(100 %)
3 diff
(99.6 %id)
DB341186 testis .e 3016 to 3549 535 to 1       535/535
(100 %)
2 diff
(99.7 %id)
BF796115 lymph, lymphoma, cell line .e 3239 to 3947 1 to 710   tiling clone,   710/1064
(66 %)
14 diff
(98.7 %id)
CD710312 normal nasopharynx .e 3244 to 3745 22 to 523       502/523
(95 %)
7 diff
(98.7 %id)
AV712328   .e 3327 to 3828 1 to 502       502/502
(100 %)
24 diff
(95.3 %id)
AL040201 testis .f 1 to 833 1 to 833   tiling clone,   833/833
(100 %)
2 diff
(99.8 %id)
BQ310517 breast .f 534 to 992 468 to 12   tiling clone,   457/471
(97 %)
8 diff
(98.4 %id)
CN422366 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .g 1 to 785 1 to 785 exact tiling clone,   785/785
(100 %)
2 diff
(99.8 %id)
BU078155 Pancreas, Purified pancreatic islet .h 1 to 465 47 to 511   fully sequenced,   465/511
(90 %)
6 diff
(98.9 %id)
BU952221 Pancreas, Purified pancreatic islet .h 1 to 617 40 to 656   tiling clone,   617/656
(94 %)
8 diff
(98.8 %id)
CK902325 Pancreas, Purified pancreatic islet .h 15 to 575 54 to 615     Submitted on the opposite strand 562/617
(91 %)
25 diff
(96.0 %id)
CA775397 Pancreas, Purified pancreatic islet .h 15 to 347 42 to 374   fully sequenced,   333/374
(89 %)
6 diff
(98.4 %id)
BQ788065 Pancreas, Purified pancreatic islet .h 75 to 697 623 to 1       623/623
(100 %)
0 diff
(100 %id)
CK902326 Pancreas, Purified pancreatic islet .h 130 to 628 499 to 1     Submitted on the opposite strand 499/499
(100 %)
1 diff
(99.8 %id)
CA775155 Pancreas, Purified pancreatic islet .h 317 to 662 346 to 1   fully sequenced,   346/346
(100 %)
0 diff
(100 %id)
AI609558 brain, tumor, 5 pooled (see description) .h 357 to 707 351 to 1   tiling clone,   351/351
(100 %)
0 diff
(100 %id)
BU077910 Pancreas, Purified pancreatic islet .h 404 to 697 294 to 1   fully sequenced,   294/294
(100 %)
0 diff
(100 %id)
BP218952 caudate nucleus .i-u 1 to 564 1 to 563   tiling clone,   563/594
(94 %)
7 diff
(98.9 %id)
BI020928 marrow .i-u 22 to 457 438 to 2       437/438
(99 %)
0 diff
(100 %id)
BX479502   .i-u 109 to 285 1 to 177   tiling clone,   177/177
(100 %)
0 diff
(100 %id)
T10672   .i-u 509 to 765 265 to 8   tiling clone,   258/265
(97 %)
0 diff
(100 %id)
BG720854 testis .j 1 to 700 1 to 698   tiling clone,   698/778
(89 %)
20 diff
(97.5 %id)
BU854249 testis .j 26 to 733 1 to 719 V72G Y73L K74Q Q75T A76G ... tiling clone,   719/767
(93 %)
23 diff
(97.1 %id)
AA383811 testis .j 41 to 349 1 to 310       310/310
(100 %)
1 diff
(99.7 %id)
DA716735   .k 1 to 561 2 to 563   tiling clone, capped   562/562
(100 %)
1 diff
(99.9 %id)
DA523291 brain .k 35 to 595 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
BP332620 renal proximal tubule .k 37 to 614 1 to 578       578/582
(99 %)
16 diff
(97.3 %id)
BY796025 eye .k 54 to 666 1 to 613   tiling clone,   613/613
(100 %)
0 diff
(100 %id)
TI_154161178   .k 54 to 729 77 to 745       669/739
(90 %)
54 diff
(92.7 %id)
AF387614   .k 383 to 774 1 to 392       392/392
(100 %)
0 diff
(100 %id)
BF332101 breast .k 394 to 843 472 to 23   tiling clone,   450/472
(95 %)
0 diff
(100 %id)
AW469549 pooled .l 1 to 445 447 to 3 P64L E146K F147I tiling clone,   445/447
(99 %)
1 diff
(99.8 %id)
BF804671 colon_ins .m 1 to 405 10 to 415 exact tiling clone,   408/415
(98 %)
6 diff
(98.6 %id)
BJ993120 hepatoblastoma .n-u 1 to 600 1 to 600   tiling clone,   600/600
(100 %)
1 diff
(99.9 %id)
BJ993121 hepatoblastoma .n-u 2063 to 2596 534 to 1 exact tiling clone,   534/535
(99 %)
0 diff
(100 %id)
DB083399 testis .o 1 to 563 2 to 564 exact capped   563/563
(100 %)
2 diff
(99.7 %id)
DB636387 testis .o 4 to 712 1 to 707 exact tiling clone,   707/707
(100 %)
5 diff
(99.3 %id)
DB085772 testis .o 5 to 573 2 to 570 exact capped   569/569
(100 %)
0 diff
(100 %id)
BG563107 Liver .p-u 1 to 675 1 to 675 C22V L23Y F25L V26* tiling clone,   675/675
(100 %)
6 diff
(99.2 %id)
BE973796 Prostate .q-u 1 to 606 7 to 603 F46L E47S Y48I F49C V50H ... tiling clone,   603/836
(72 %)
18 diff
(97.9 %id)
DB078872 testis .r -10 to 564 2 to 576 exact tiling clone, capped   575/575
(100 %)
0 diff
(100 %id)
BI461779 testis .r 1 to 521 9 to 532 W16R N35K N39K T45D D46R ...     532/532
(100 %)
19 diff
(96.5 %id)
DB074235 testis .r 1 to 537 4 to 541 exact capped   540/540
(100 %)
1 diff
(99.9 %id)
DB063208 testis .r 23 to 587 2 to 566 exact tiling clone, capped   565/565
(100 %)
0 diff
(100 %id)
DB072095 testis .r 28 to 575 2 to 549 exact capped   548/548
(100 %)
0 diff
(100 %id)
BF353698 head_neck .s-u 1 to 336 352 to 17 exact tiling clone,   336/352
(95 %)
0 diff
(100 %id)
AV763704 bone marrow .s-u 102 to 394 1 to 293   tiling clone,   293/350
(83 %)
5 diff
(98.6 %id)
CV390734 head_neck .s-u 188 to 379 193 to 4     Submitted on the opposite strand 190/193
(98 %)
0 diff
(100 %id)
AW591766 lymph node, lymphoma, follicular mixed small and largecell .s-u 195 to 583 389 to 1   tiling clone,   389/389
(100 %)
6 diff
(98.5 %id)
BP379966 uterus .t 1 to 581 1 to 581 exact tiling clone,   581/581
(100 %)
0 diff
(100 %id)
AW294423   .u 1 to 474 490 to 18 I33S V34S S35R F36S I37S ... tiling clone, AAA   473/473
(100 %)
1 diff
(99.8 %id)
AW838707 leiomios .va-u 1 to 320 340 to 5   tiling clone,   336/340
(98 %)
0 diff
(100 %id)
AW838710 leiomios .va-u 2 to 379 373 to 3   tiling clone,   371/374
(99 %)
0 diff
(100 %id)
AA876063 germinal center B cell .vb-u 1 to 298 301 to 4 exact tiling clone,   298/307
(97 %)
0 diff
(100 %id)
DW441332 Liver .vc-u 1 to 230 10 to 239 S2R H3D L41S tiling clone,   230/239
(96 %)
6 diff
(97.5 %id)
DW460527 Liver .vd-u 1 to 126 12 to 137 C2G tiling clone,   126/137
(91 %)
6 diff
(95.7 %id)
AK095601 brain Gene CEP350, variant not shown       available from FLJ, Suspected internal deletion, this clone was ignored    
BE089775 breast Gene CEP350, variant not shown         Submitted on the opposite strand    
AV712306   Gene CEP350, variant not shown         Suspected internal deletion, this clone was ignored    
AV681978 hepatocellular carcinoma Gene CEP350, variant not shown         Suspected internal deletion, this clone was ignored    
DB084370 testis Gene CEP350, variant not shown       capped This clone was ignored    
DB341033 testis Gene CEP350, variant not shown         This clone was ignored    
DB150271 thymus Gene CEP350, variant not shown       capped      
DB346065 thymus Gene CEP350, variant not shown              
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i-u, .j, .k, .l, .m, .n-u, .o, .p-u, .q-u, .r, .s-u, .t, .u, .va-u, .vb-u, .vc-u, .vd-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI